Article By:
The Fly
Wednesday, February 27, 2019 9:25 AM EDT
Merck KGaA has proposed to the board of directors of Versum Materials that Merck should acquire all of the issued and outstanding common shares of Versum for $48 per share or an enterprise value of $5.9B in an all-cash transaction.